Drugs for Movement Disorders Flashcards
MOA: “-dopa”
Levodopa and combinations
Levodopa
Carbidopa
What are the DA receptor agonists? (4)
Apomorphine
Bromocriptine
Pramipexole
Ropinirole
What are the MAO inhibitors used for Parkinson’s? (3)
Rasagiline
Selegiline
Safinamide
What are the catechol-O-methyltransferase inhibitors? (2)
Entacapone
Tolcapone
What are the anticholinergic drugs used in Parkinson’s? (5)
Benztropine Biperidin Orphenadrine Procyclidine Trihexyphenidyl
What is the use of Carbidopa when used with Levodopa?
It is a DOPA decarboxylase inhibitor, thus it ensures that a greater amount of Levodopa crosses the BBB unscathed.
-reduces daily Levodopa needs by 75%
When is Carbidopa most effective?
The first few years of treatment.
What “phenomenon” can ensue after use of Levodopa?
How many people respond to the drug?
“Wearing-off” phenomenon: each dose of Levo effectively improves mobility for a period of time (12 hrs.), but rigidity and akinesia returns rapidly at the end of the dosing interval.
1/3 respond well, 1/3 respond less well, 1/3 are unable to take the medicine or don’t respond at all
What is a significant side-effect of Levodopa if not taken with Carbidopa?
GI-related: anorexia, nausea, vomiting (+ of chemoreceptor trigger zone) in 80% of patients.
If taken w/ Carbidopa, there is less risk for Gi-related problems.
What side-effects (aside from GI-related) are associated with Levodopa? (4 + GI)
CV effects - postural hypotension (often diminishes w/ repeated treatment). HTN may occur if taken in large doses or in combo w/ nonselective MAOIs/sympatheticomimetcs.
Dyskinesias - occurs in 80% of patients. Choreoathetosis of the face and distal extremities.
Behavioral effects - depression, anxiety, agitation, insomnia, etc. Atypical antipsychotics can help counteract behavioral problems.
Fluctuations in response and the “off and on” response.
What can help patients experiencing the “off and on” phenomenon?
Apomorphine
What are the contraindications of Levodopa use? (5)
Patients taking MAOIs (or within 2 wks. of discontinuation) may cause a HTN crisis.
Psychotic patients
Patients w/ closed-angle glaucoma
Patients with a history of melanoma/skin lesions
Use w/ caution in patients with active PUD
What is the indication for use of DA receptor agonists in patients taking Levodopa/Carbidopa?
End-of-dose akinesia or on-off phenomenon
What is the benefit of DA receptor agonists?
Less incidence of fluctuations and dyskinesias with long-term Levo therapy
What is the MOA of Bromocriptine?
What is it indicated for in addition to PD?
What is the unique problem with it?
Ergot alkaloid derivative that is a D2 agonist.
Endocrine disorders.
Extensive first-pass metabolism (28% bioavailability).